Poor health-related quality of life despite Lupus Low Disease Activity State or Definitions of Remission in systemic lupus erythematosus (SLE) remission in patients with SLE: results from a clinical trial setting
Despite LLDAS or DORIS remission, notable proportions of SLE patients report poor HRQoL, indicating that current therapeutic goal definitions do not fully capture patients' perspectives of health.
Authors
- Julius Lindblom
- Leonardo Palazzo (ORCID: https://orcid.org/0000-0002-2652-7447)
- Vibeke Strand (ORCID: https://orcid.org/0000-0003-4978-4072)
- Mandana Nikpour (ORCID: https://orcid.org/0000-0002-6585-5611)
- Adrian Levitsky (ORCID: https://orcid.org/0000-0003-4821-0691)
- Alexander Tsoi (ORCID: https://orcid.org/0009-0004-4815-7477)
- Ioannis Parodis (ORCID: https://orcid.org/0000-0002-4875-5395)
- Nurşen Çetrez (ORCID: https://orcid.org/0000-0001-9874-841X)
- Henri Ala
Institutions
- The University of Sydney (AU)
- Karolinska University Hospital (SE)
- Örebro University (SE)
- Royal Prince Alfred Hospital (AU)
- Stanford University (US)
Publication Details
- Journal
- RMD Open
- Published
- 2025-10-01
- DOI
- https://doi.org/10.1136/rmdopen-2025-006061
- Citations
- 2
- Primary Topic
- Systemic Lupus Erythematosus Research
- Type
- article
- Field-Weighted Citation Impact
- 3.34
Funders
- GlaxoSmithKline
- Karolinska Institutet
- Svenska Läkaresällskapet
- Stiftelsen Konung Gustaf V:s 80-årsfond
- Reumatikerförbundet